|
Volumn 19, Issue 1, 2013, Pages 29-35
|
Antiviral efficacies of currently available rescue therapies for multidrug-resistant chronic hepatitis B.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ADEFOVIR;
ADEFOVIR DIPIVOXIL;
ADENINE;
ANTIVIRUS AGENT;
DRUG DERIVATIVE;
ENTECAVIR;
GUANINE;
HEPATITIS B(E) ANTIGEN;
LAMIVUDINE;
PHOSPHONIC ACID DERIVATIVE;
VIRUS DNA;
ADULT;
AGED;
ANTIVIRAL RESISTANCE;
ARTICLE;
BLOOD;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG COMBINATION;
FEMALE;
FOLLOW UP;
GENETICS;
GENOTYPE;
HEPATITIS B;
HEPATITIS B VIRUS;
HUMAN;
MALE;
MIDDLE AGED;
MULTIDRUG RESISTANCE;
TREATMENT OUTCOME;
ADEFOVIR;
ENTECAVIR;
HEPATITIS B;
HEPATITIS B VIRUS;
MULTIDRUG RESISTANCE;
ADENINE;
ADULT;
AGED;
ANTIVIRAL AGENTS;
DNA, VIRAL;
DRUG RESISTANCE, VIRAL;
DRUG THERAPY, COMBINATION;
FEMALE;
FOLLOW-UP STUDIES;
GENOTYPE;
GUANINE;
HEPATITIS B E ANTIGENS;
HEPATITIS B VIRUS;
HEPATITIS B, CHRONIC;
HUMANS;
LAMIVUDINE;
MALE;
MIDDLE AGED;
ORGANOPHOSPHONATES;
TREATMENT OUTCOME;
|
EID: 84886891613
PISSN: None
EISSN: 2287285X
Source Type: None
DOI: 10.3350/cmh.2013.19.1.29 Document Type: Article |
Times cited : (10)
|
References (0)
|